Latest Blogs

Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Jun 19, 2019
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
Jun 11, 2019
I am excited about the entire Breakthrough program, including a session I am leading on the impact of social media and telehealth on cancer care.
Jun 11, 2019
Real actions that promote women and under-represented groups in medicine are doable, starting today.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and a professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon on Twitter @drdonsdizon.

Jun 19, 2018
This was a patient who needed to do cancer her way, and making it about me was not going to work.
Jun 07, 2018
FASCO is something earned through service to ASCO and to the field of oncology. One cannot apply or pay a fee to receive it.
May 22, 2018
Sometimes cross-coverage means having hard conversations with patients who aren't ours, but who still deserve our expertise and our honesty.
Apr 24, 2018
For those not in our field, cancer is still seen as a devastating disease starting at the point of diagnosis. As oncology professionals, it’s important that we do not accept death from cancer as inevitable, or even as imminent.
Apr 17, 2018
Clinical trials are the pathway to better treatments, better outcomes, and a future without cancer. We, as investigators, need to believe in them, and be willing to offer them to all patients who are eligible. 
Mar 22, 2018
A trial of aqueous lidocaine to manage painful intercourse for breast cancer survivors was a small study with a great magnitude of benefit. Do we need to wait for more data, or can we start applying these findings for our patients today?

Pages